Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jul 24, 2023; 14(7): 265-284
Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.265
Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.265
Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery
Juliet C Panichella, Samuel G Robinson, Susan You, Sarah M Gubara, Maria T Gebreyesus, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, United States
Sthefano Araya, Siddhartha Nannapaneni, Sameer A Patel, Division of Plastic and Reconstructive Surgery, Fox Chase Cancer Center, Philadelphia, PA 19111, United States
Theresa Webster, Department of Plastic Surgery, Temple University, Philadelphia, PA 18045, United States
Alireza Hamidian Jahromi, Division of Plastic and Reconstructive Surgery, Temple University Hospitals, Philadelphia, PA 19140, United States
Author contributions: All authors contributed in a significant and meaningful way to the development of this article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article. Accepted as poster presentation at Plastic Surgery the Meeting October 27th-30th 2022, Boston, Massachusetts.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Alireza Hamidian Jahromi, MD, MRCS, Division of Plastic and Reconstructive Surgery, Temple University Hospitals, 3401 Broad Street, Philadelphia, PA 19140, United States. alirezahamidian@yahoo.com
Received: December 28, 2022
Peer-review started: December 28, 2022
First decision: April 13, 2023
Revised: May 15, 2023
Accepted: June 27, 2023
Article in press: June 27, 2023
Published online: July 24, 2023
Processing time: 202 Days and 15.5 Hours
Peer-review started: December 28, 2022
First decision: April 13, 2023
Revised: May 15, 2023
Accepted: June 27, 2023
Article in press: June 27, 2023
Published online: July 24, 2023
Processing time: 202 Days and 15.5 Hours
Core Tip
Core Tip: Currently, a comprehensive guideline for cancer screening in the transgender and gender diverse (TGGD) population is lacking. Caring for the TGGD population undergoing Gender Affirmation Surgery is highly individualized and requires consideration of factors such as age at which individuals commenced hormonal therapy and the stage of transition. Once diagnosed with cancer, TGGD patients should receive care at institutions capable of providing a multi-disciplinary approach. This collective approach will ensure record upkeep and help delay any unnecessary delays in care.